Novartis Japan Sets Up Special Call Center For Diovan Patients
This article was originally published in PharmAsia News
Amidst the alleged irregularities in clinical trial data regarding the ARB Diovan, Novartis Japan has set up a call center dedicated to helping patients who feel anxious about taking the drug.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?